Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: PROSTATE CANCER, . Treffer: 235

2023

Bögemann, M; Facchini, G; Bauernhofer, T; Cathomas, R; Xylinas, E; Tombal, B Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practice.
Ir J Med Sci. 2023; Doi: 10.1007/s11845-023-03303-y
Web of Science PubMed FullText FullText_MUG

 

Plhak, E; Pichler, C; Gößnitzer, E; Aigner, RM; Kvaternik, H Development of in-House Synthesis and Quality Control of [^99mTc]Tc-PSMA-I&S.
Molecules. 2023; 28(2): Doi: 10.3390/molecules28020577 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weitzer, F; Pernthaler, B; Plhak, E; Riedl, R; Aigner, RM Diagnostic value of two-time point [⁶⁸Ga]Ga-PSMA-11 PET/CT in the primary staging of untreated prostate cancer.
Sci Rep. 2023; 13(1): 8297 Doi: 10.1038/s41598-023-35628-0
PubMed FullText FullText_MUG

 

2022

Blomme, A; Peter, C; Mui, E; Rodriguez, Blanco, G; An, N; Mason, LM; Jamieson, LE; McGregor, GH; Lilla, S; Ntala, C; Patel, R; Thiry, M; Kung, SHY; Leclercq, M; Ford, CA; Rushworth, LK; McGarry, DJ; Mason, S; Repiscak, P; Nixon, C; Salji, MJ; Markert, E; MacKay, GM; Kamphorst, JJ; Graham, D; Faulds, K; Fazli, L; Gleave, ME; Avezov, E; Edwards, J; Yin, H; Sumpton, D; Blyth, K; Close, P; Murphy, DJ; Zanivan, S; Leung, HY THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer.
EMBO Mol Med. 2022; 14(3): e14764 Doi: 10.15252/emmm.202114764 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gawish, A; Abdulayev, N; El-Arayed, S; Rollich, B; Ochel, HJ; Brunner, TB Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer
CLIN TRANSL ONCOL. 2022; Doi: 10.1007/s12094-022-03002-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heidegger, I; Fotakis, G; Offermann, A; Goveia, J; Daum, S; Salcher, S; Noureen, A; Timmer-Bosscha, H; Schäfer, G; Walenkamp, A; Perner, S; Beatovic, A; Moisse, M; Plattner, C; Krogsdam, A; Haybaeck, J; Sopper, S; Thaler, S; Keller, MA; Klocker, H; Trajanoski, Z; Wolf, D; Pircher, A Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
Mol Cancer. 2022; 21(1): 132 Doi: 10.1186/s12943-022-01597-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Juracek, J; Madrzyk, M; Stanik, M; Ruckova, M; Trachtova, K; Malcikova, H; Lzicarova, E; Barth, DA; Pichler, M; Slaby, O A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer
PROSTATE. 2022; Doi: 10.1002/pros.24466
Web of Science PubMed FullText FullText_MUG

 

Leitsmann, C; Uhlig, A; Bremmer, F; Mut, TT; Ahyai, S; Reichert, M; Leitsmann, M; Trojan, L; Popeneciu, IV Impact of mpMRI targeted biopsy on intraoperative nerve-sparing (NeuroSAFE) during robot-assisted laparoscopic radical prostatectomy.
Prostate. 2022; 82(4):493-501 Doi: 10.1002/pros.24295
Web of Science PubMed FullText FullText_MUG

 

Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, GP; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Strobl, J; Hutterer, GC; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Front Surg. 2022; 9: 1013389 Doi: 10.3389/fsurg.2022.1013389 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pratsinis, M; Fankhauser, C; Pratsinis, K; Beyer, J; Bührer, E; Cathomas, R; Fischer, N; Hermanns, T; Hirschi-Blickenstorfer, A; Kamradt, J; Alex, Kluth, L; Zihler, D; Mingrone, W; Müller, B; Nestler, T; Rothschild, SI; Seifert, B; Templeton, AJ; Terbuch, A; Ufen, MP; Woelky, R; Gillessen, S; Rothermundt, C Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Eur Urol Open Sci. 2022; 40: 16-18. Doi: 10.1016/j.euros.2022.03.013 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2021

Glechner, A; Rabady, S; Bachler, H; Dachs, C; Flamm, M; Glehr, R; Hoffmann, K; Hoffmann-Dorninger, R; Kamenski, G; Lutz, M; Poggenburg, S; Tschiggerl, W; Horvath, K A Choosing Wisely top-5 list to support general practitioners in Austria.
Wien Med Wochenschr. 2021; Doi: 10.1007/s10354-021-00846-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lodeta, B; Trkulja, V; Kolroser-Sarmiento, G; Jozipovic, D; Salmhofer, A; Augustin, H Systematic biopsy should not be omitted in the era of combined magnetic resonance imaging/ultrasound fusion-guided biopsies of the prostate.
Int Urol Nephrol. 2021; 53(11): 2251-2259. Doi: 10.1007/s11255-021-02989-2
Web of Science PubMed FullText FullText_MUG

 

Martinez, RS; Salji, MJ; Rushworth, L; Ntala, C; Rodriguez, Blanco, G; Hedley, A; Clark, W; Peixoto, P; Hervouet, E; Renaude, E; Kung, SHY; Galbraith, LCA; Nixon, C; Lilla, S; MacKay, GM; Fazli, L; Gaughan, L; Sumpton, D; Gleave, ME; Zanivan, S; Blomme, A; Leung, HY SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer.
Cancer Res. 2021; 81(13):3664-3678 Doi: 10.1158/0008-5472.CAN-20-3694
Web of Science PubMed FullText FullText_MUG

 

Mirzaei, S; Lipp, R; Zandieh, S; Leisser, A Single-Center Comparison of [Cu-64]-DOTAGA-PSMA and [F-18]-PSMA PET-CT for Imaging Prostate Cancer
CURR ONCOL. 2021; 28(5): 4167-4173. Doi: 10.3390/curroncol28050353 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pernthaler, B; Nazerani Hooshmand, T; Igrec, J; Kvaternik, H; Aigner, RM Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT.
Clin Nucl Med. 2021; 46(4):e231-e232-e231-e232 Doi: 10.1097/RLU.0000000000003347
Web of Science PubMed FullText FullText_MUG

 

Schneider, R; Gademann, G; Ochel, HJ; Neumann, K; Jandrig, B; Hass, P; Walke, M; Schostak, M; Brunner, T; Christoph, F Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145.
Radiat Oncol. 2021; 16(1): 137 Doi: 10.1186/s13014-021-01859-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weitzer, F; Nazerani-Hooshmand, T; Aigner, RM; Pernthaler, B Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
Clin Nucl Med. 2021; 46(7): e358-e359-e358-e359. Doi: 10.1097/RLU.0000000000003538
Web of Science PubMed FullText FullText_MUG

 

Wenzel, M; Welte, MN; Grossmann, L; Preisser, F; Theissen, LH; Humke, C; Deuker, M; Bernatz, S; Gild, P; Ahyai, S; Karakiewicz, PI; Bodelle, B; Kluth, LA; Chun, FKH; Mandel, P; Becker, A Multiparametric MRI may Help to Identify Patients With Prostate Cancer in a Contemporary Cohort of Patients With Clinical Bladder Outlet Obstruction Scheduled for Holmium Laser Enucleation of the Prostate (HoLEP).
Front Surg. 2021; 8: 633196 Doi: 10.3389/fsurg.2021.633196 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wulczyn, E; Nagpal, K; Symonds, M; Moran, M; Plass, M; Reihs, R; Nader, F; Tan, F; Cai, Y; Brown, T; Flament-Auvigne, I; Amin, MB; Stumpe, MC; Müller, H; Regitnig, P; Holzinger, A; Corrado, GS; Peng, LH; Chen, PC; Steiner, DF; Zatloukal, K; Liu, Y; Mermel, CH Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading.
Commun Med (Lond). 2021; 1: 10 Doi: 10.1038/s43856-021-00005-3 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Zhang, J; Rakhimbekova, A; Duan, X; Yin, Q; Foss, CA; Fan, Y; Xu, Y; Li, X; Cai, X; Kutil, Z; Wang, P; Yang, Z; Zhang, N; Pomper, MG; Wang, Y; Bařinka, C; Yang, X A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging.
Nat Commun. 2021; 12(1): 5460 Doi: 10.1038/s41467-021-25746-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Barth, DA; Juracek, J; Slaby, O; Pichler, M; Calin, GA lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082148 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Blomme, A; Ford, CA; Mui, E; Patel, R; Ntala, C; Jamieson, LE; Planque, M; McGregor, GH; Peixoto, P; Hervouet, E; Nixon, C; Salji, M; Gaughan, L; Markert, E; Repiscak, P; Sumpton, D; Blanco, GR; Lilla, S; Kamphorst, JJ; Graham, D; Faulds, K; MacKay, GM; Fendt, SM; Zanivan, S; Leung, HY 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer.
Nat Commun. 2020; 11(1):2508 Doi: 10.1038/s41467-020-16126-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Brausi, M; Hoskin, P; Andritsch, E; Banks, I; Beishon, M; Boyle, H; Colecchia, M; Delgado-Bolton, R; Höckel, M; Leonard, K; Lövey, J; Maroto, P; Mastris, K; Medeiros, R; Naredi, P; Oyen, R; de Reijke, T; Selby, P; Saarto, T; Valdagni, R; Costa, A; Poortmans, P ECCO Essential Requirements for Quality Cancer Care: Prostate cancer.
Crit Rev Oncol Hematol. 2020; 148: 102861-102861. Doi: 10.1016/j.critrevonc.2019.102861
Web of Science PubMed FullText FullText_MUG

 

Fischbach, F; Hass, P; Schindele, D; Genseke, P; Geisendorf, L; Stehning, C; Schostak, M; Brunner, T; Pech, M; Fischbach, K MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL).
Eur Radiol. 2020; 30(4):2072-2081 Doi: 10.1007/s00330-019-06505-0
Web of Science PubMed FullText FullText_MUG

 

Hofmann, L; Kroneis, T; El-Heliebi, A Using In Situ Padlock Probe Technology to Detect mRNA Splice Variants in Tumor Cells.
Methods Mol Biol. 2020; 2148: 361-378. Doi: 10.1007/978-1-0716-0623-0_23
PubMed FullText FullText_MUG

 

Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082247 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kaiser, M; Thurner, EM; Mangge, H; Herrmann, M; Semeraro, MD; Renner, W; Langsenlehner, T Haptoglobin polymorphism and prostate cancer mortality.
Sci Rep. 2020; 10(1): 13117-13117. Doi: 10.1038/s41598-020-69333-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lu, C; Terbuch, A; Dolling, D; Yu, J; Wang, H; Chen, Y; Fountain, J; Bertan, C; Sharp, A; Carreira, S; Isaacs, WB; Antonarakis, ES; De Bono, JS; Luo, J Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype.
Ann Oncol. 2020; 31(9):1178-1185 Doi: 10.1016/j.annonc.2020.04.473
Web of Science PubMed FullText FullText_MUG

 

Mirzaei, S; Lipp, RW Peptide and pseudo-peptide.
Q J Nucl Med Mol Imaging. 2020; 64(4):364-370 Doi: 10.23736/S1824-4785.20.03311-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moritz, J; Bauernhofer, T; Mannweiler, S; Langsenlehner, T; Pummer, K; Dandachi, N; Pichler, M Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients.
In Vivo. 2020; 34(6): 3631-3638. Doi: 10.21873/invivo.12209 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ryszawy, D; Pudełek, M; Kochanowski, P; Janik-Olchawa, N; Bogusz, J; Rąpała, M; Koczurkiewicz, P; Mikołajczyk, J; Borek, I; Kędracka-Krok, S; Karnas, E; Zuba-Surma, E; Madeja, Z; Czyż, J High bisphenol A concentrations augment the invasiveness of tumor cells through Snail-1/Cx43/ERRγ-dependent epithelial-mesenchymal transition.
Toxicol In Vitro. 2020; 62(1):104676-104676 Doi: 10.1016/j.tiv.2019.104676 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schaefer, C; Zamboglou, C; Volegova-Neher, N; Martini, C; Nicolay, NH; Schmidt-Hegemann, NS; Rogowski, P; Li, M; Belka, C; Müller, AC; Grosu, AL; Brunner, T Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer - a prospective pilot study.
Radiat Oncol. 2020; 15(1):27 Doi: 10.1186/s13014-020-1474-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Beer, L; Polanec, SH; Baltzer, PAT; Schatzl, G; Georg, D; Schestak, C; Dutschke, A; Herrmann, H; Mazal, P; Brendel, AK; Shariat, SF; Ringl, H; Helbich, TH; Apfaltrer, P 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
PLoS One. 2019; 14(12):e0225673-e0225673 Doi: 10.1371/journal.pone.0225673 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Calabria, F; Pichler, R; Leporace, M; Wolfsgruber, J; Coscarelli, P; Dunzinger, A; Schillaci, O; Cascini, GL; Bagnato, A 68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers.
Curr Radiopharm. 2019; 12(3):238-246 Doi: 10.2174/1874471012666190515090755
Web of Science PubMed FullText FullText_MUG

 

Chen, S; Tauber, G; Langsenlehner, T; Schmölzer, LM; Pötscher, M; Riethdorf, S; Kuske, A; Leitinger, G; Kashofer, K; Czyż, ZT; Polzer, B; Pantel, K; Sedlmayr, P; Kroneis, T; El-Heliebi, A In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy.
Cancers (Basel). 2019; 11(7): Doi: 10.3390/cancers11070933 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Duijvesz, D; Rodriguez-Blanco, G; Hoogland, AM; Verhoef, EI; Dekker, LJ; Roobol, MJ; van, Leenders, GJLH; Luider, TM; Jenster, G Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.
Prostate. 2019; 79(9): 1032-1042. Doi: 10.1002/pros.23813 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kardoust Parizi, M; Iwata, T; Kimura, S; Janisch, F; Abufaraj, M; Karakiewicz, PI; Enikeev, D; Rapoport, LM; Hutterer, G; Shariat, SF Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2019; 20(6): 1374 Doi: 10.3390/ijms20061374 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mahmoudian, J; Ghods, R; Nazari, M; Jeddi-Tehrani, M; Ghahremani, MH; Ghaffari-Tabrizi-Wizsy, N; Ostad, SN; Zarnani, AH PLAC1: biology and potential application in cancer immunotherapy.
Cancer Immunol Immunother. 2019; 68(7): 1039-1058. Doi: 10.1007/s00262-019-02350-8
Web of Science PubMed FullText FullText_MUG

 

Pernthaler, B; Kulnik, R; Gstettner, C; Salamon, S; Aigner, RM; Kvaternik, H A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT.
Clin Nucl Med. 2019; 44(10): e566-e573-e566-e573. Doi: 10.1097/RLU.0000000000002703
Web of Science PubMed FullText FullText_MUG

 

Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666. Doi: 10.1038/s41467-019-12714-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Ulz, P; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, W; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.
Int J Cancer. 2018; 143(5): 1236-1248. Doi: 10.1002/ijc.31397 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Borgmann, H; Salem, J; Baunacke, M; Boehm, K; Groeben, C; Schmid, M; Siegel, FP; Huber, J Mapping the landscape of urology: A new media-based cross-sectional analysis of public versus academic interest.
Int J Urol. 2018; 25(5):421-428 Doi: 10.1111/iju.13527
Web of Science PubMed FullText FullText_MUG

 

Chen, S; El-Heliebi, A; Schmid, J; Kashofer, K; Czyż, ZT; Polzer, BM; Pantel, K; Kroneis, T; Sedlmayr, P Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization.
J Vis Exp. 2018; (135): Doi: 10.3791/56394 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

de Wit, S; Manicone, M; Rossi, E; Lampignano, R; Yang, L; Zill, B; Rengel-Puertas, A; Ouhlen, M; Crespo, M; Berghuis, AMS; Andree, KC; Vidotto, R; Trapp, EK; Tzschaschel, M; Colomba, E; Fowler, G; Flohr, P; Rescigno, P; Fontes, MS; Zamarchi, R; Fehm, T; Neubauer, H; Rack, B; Alunni-Fabbroni, M; Farace, F; De Bono, J; IJzerman, MJ; Terstappen, LWMM EpCAM^high and EpCAM^low circulating tumor cells in metastatic prostate and breast cancer patients.
Oncotarget. 2018; 9(86):35705-35716 Doi: 10.18632/oncotarget.26298 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

El-Heliebi, A; Hille, C; Laxman, N; Svedlund, J; Haudum, C; Ercan, E; Kroneis, T; Chen, S; Smolle, M; Rossmann, C; Krzywkowski, T; Ahlford, A; Darai, E; von Amsberg, G; Alsdorf, W; König, F; Löhr, M; de Kruijff, I; Riethdorf, S; Gorges, TM; Pantel, K; Bauernhofer, T; Nilsson, M; Sedlmayr, P In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.
Clin Chem. 2018; 64(3):536-546 Doi: 10.1373/clinchem.2017.281295 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heitzer, E; Speicher, MR Digital Circulating Tumor Cell Analyses for Prostate Cancer Precision Oncology.
Cancer Discov. 2018; 8(3): 269-271. Doi: 10.1158/2159-8290.CD-18-0075 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Markou, A; Lazaridou, M; Paraskevopoulos, P; Chen, S; Świerczewska, M; Budna, J; Kuske, A; Gorges, TM; Joosse, SA; Kroneis, T; Zabel, M; Sedlmayr, P; Alix-Panabières, C; Pantel, K; Lianidou, ES Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
Clin Chem. 2018; 64(2):297-306 Doi: 10.1373/clinchem.2017.275503 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mischinger, J; Kaufmann, S; Russo, GI; Harland, N; Rausch, S; Amend, B; Scharpf, M; Loewe, L; Todenhoefer, T; Notohamiprodjo, M; Nikolaou, K; Stenzl, A; Bedke, J; Kruck, S Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy.
BJU Int. 2018; 121(5):791-798 Doi: 10.1111/bju.14089 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583 Doi: 10.1038/s41391-018-0068-3
Web of Science PubMed FullText FullText_MUG

 

Rodríguez-Blanco, G; Zeneyedpour, L; Duijvesz, D; Hoogland, AM; Verhoef, EI; Kweldam, CF; Burgers, PC; Smitt, PS; Bangma, CH; Jenster, G; van, Leenders, GJLH; Dekker, LJM; Luider, TM Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer.
Oncotarget. 2018; 9(92): 36444-36456. Doi: 10.18632/oncotarget.26342 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum